Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Director dealings: Man Group non-exec invests, Seeing Machines discloses several transactions
(Sharecast News) - Two notable director dealings disclosed to the London market on Tuesday involved transactions in shares of Man Group and Seeing Machines. At Man Group, non-executive director Laurie Fitch purchased 7,390 ordinary shares at a price of 213.196p each.
The transaction was executed on 31 December on the London Stock Exchange.
Seeing Machines meanwhile reported multiple director transactions.
Lombard Odier Asset Management, closely associated with non-executive director Michael Brown, sold 159,652,749 shares at 4.09p apiece on 24 December.
The sale reduced Lombard's holdings to 485,230,164 shares, equivalent to 9.87% of the company's issued share capital.
Seeing Machines said the sale facilitated Mitsubishi Electric's acquisition of shares to achieve a 19.9% stake in the company, a move it described as a "milestone transaction".
Additionally, on 30 December, Seeing Machines' chief financial officer Martin Ive purchased 96,750 shares at 4.65p each, bringing his total holding to 8,022,980 shares, representing 0.16% of the company's issued share capital.
On the same day, chair Kate Hill acquired 200,000 shares at 4.8p apiece, increasing her stake to 5,000,000 shares, equivalent to 0.1% of the company's issued share capital.
At 1229 GMT, shares in Man Group were up 1.13% at 214p, while those in Seeing Machines were down 1.03% at 4.65p.
Reporting by Josh White for Sharecast.com.
Top Director Buys
Man Group (EMG) Director name: Fitch,Laurie Amount purchased: 7,390 @ 213.20p Value: £15,755.18
Seeing Machines Ltd. Npv (di) (SEE) Director name: Hill,Kate Amount purchased: 200,000 @ 4.80p Value: £9,600.00
Mortgage Advice Bureau (holdings) (MAB1) Director name: Imlach,Nathan James McLean Amount purchased: 331 @ 642.00p Value: £2,125.02
Top Director Sells
Seeing Machines Ltd. Npv (di) (SEE) Director name: Brown,Michael Amount sold: 159,652,752 @ 4.90p Value: £7,822,984.64
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 1,431 @ $4.00 Value: $4,720.05
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 300 @ $4.01 Value: $992.00
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 210 @ $3.99 Value: $691.80
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 200 @ $4.02 Value: $662.98
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 200 @ $4.01 Value: $662.16
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 200 @ $4.01 Value: $661.50
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 200 @ $4.00 Value: $659.85
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 153 @ $4.03 Value: $508.44
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 56 @ $4.06 Value: $187.48
Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 50 @ $4.01 Value: $165.13
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
